Scientists have designed a new artificial intelligence model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease.
Medtronic’s ablation sales slowed by PFA supply issues
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q2 FY2025 revenue: $8.4